Compare Novavax Inc (NVAX) vs TORM plc (TRMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs TORM plc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while TORM plc trades at $29.89 (market cap $2.99B). The key difference: TORM plc is far larger — about 2.3× Novavax Inc's market cap, and TORM plc pays a 9.62% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | TRMD | |
|---|---|---|
Market Cap | $1.30B | $2.99B |
Sector | Health | Technology |
52-Week High | $11.19 | $34.87 |
52-Week Low | $6.22 | $17.50 |
Enterprise Value | $800.50M | $3.88B |
Dividend Yield | — | 9.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →
